These proteins are independent prognostic factors for survival in patients with resected NSCLC, however, compared with Mcm7 and Ki67, NEK2 is a more effective proliferative factor for NSCLC prognosis. This evidence concerns the gene MCM7 and non-small cell lung carcinoma.